No reported Insider Trades available for ebisu global opportunities fund in the Trendlyne database.
ebisu global opportunities fund's has made SAST transactions in Balaxi Pharmaceuticals Ltd. recently where a Sale of 500,000 Equity shares done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balaxi Pharma | EBISU Global Opportunities Fund Limited | Sale | 09 Jun 2025 | 500,000 | 2,675,137 (0%) | - | - | 02 Jun 2025 03 Jun 2025 |
SAST (Reg29(2)) | Equity shares | Open Market | ||
| Balaxi Pharma | EBISU Global Opportunities Fund Limited | Sale | 03 May 2025 | 1,345,891 | 3,175,137 (0%) | - | - | 19 Mar 2025 24 Apr 2025 |
SAST (Reg29(2)) | Equity shares | Open Market | ||
| Balaxi Pharma | EBISU Global Opportunities Fund Limited | Acquisition | 03 May 2025 | 4,521,028 | 4,521,028 | - | - | 03 Mar 2025 03 Mar 2025 |
SAST (Reg29(1)) | Equity shares | Open Market | ||
| Balaxi Pharma | EBISU Global opportunities fund limited | Acquisition | 06 Mar 2025 | 4,521,028 | 4,521,028 | - | - | 03 Mar 2025 03 Mar 2025 |
SAST (Reg29(1)) | Equity shares | Open Market | ||
| Eraaya Lifespaces | EBISU Global Opportunities Fund Ltd | Other | Acquisition | 22 Aug 2024 | 1,250,000 | 1,250,000 (6.79%) | 6.79% | - | 13 Aug 2024 13 Aug 2024 |
SAST (29(1)) | - | Qualified Institutional Placement (qip) |